Overview
Continuous Subcutaneous Insulin Infusion (CSII) Therapy involves an external insulin pump that delivers a continuous flow of insulin through a cannula placed in subcutaneous tissue. CSII provides a more physiologic delivery of insulin resulting in a more consistent blood glucose profile and a decreased risk of developing long-term complications. The goals of CSII include: improved overall metabolic measures; avoidance of hypoglycemia, hyperglycemia, and ketoacidosis; improved self-management health behaviors and an improved quality of life.
The
The
Disetronic Medical Systems, Inc. is dedicated to the improvement of diabetes management for pump users and to assist members of the diabetes healthcare team by expanding choices and providing practical and progressive advancements in insulin delivery.
Disetronic has been helping people treat diabetes since the company was founded in Switzerland in 1984. We have a variety of specialists, from Clinical to Insurance Reimbursement, to assist you and your patients in a successful pump program. It is our wish that you will allow Disetronic to be a partner in offering your patients better control of their diabetes and better control of their lives.

